ArticlePediatrics2025
Cannabis Access by Retailer Type in New York.
Article in Pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Labeling of Cannabis Products From Licensed and Unlicensed Retailers in New York.American journal of preventive medicine · 2025Article
- Opportunities for Use: Explaining Associations Between Retail Availability and Use of Alcohol and Cannabis Among Youth.Drug and alcohol review · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveIncreasing state-level cannabis legalization in the United States aims to reduce risks to consumers through regulation but may also lead to more unlicensed retailers and youth access. This study examines how age verification and business practices (eg, pricing, signage, and youth-appealing products) differ by licensing status.
methodsThe Cannabis Access and Safety in New York (CASNY) secret shopper study observed 37 dispensaries and smoke shops (5 licensed medical, 7 licensed recreational, 10 unlicensed dispensaries, and 15 smoke shops), randomly selected from 840 outlets across New York City (NYC) in November to December 2023 to audit age verification and other business practices.
resultsLicensed retailers were significantly more likely to require age verification before store entry (100% vs 10%, P < .01) and purchase (100% vs 48%, P = .01). Unlicensed retailers displayed more cartoon signage (57% vs 0%) and sold youth-appealing products like energy drinks (48% vs 0%), soda (57% vs 0%), and candy (53% vs 0%). Both types of retailers were often near schools (75% and 76%) and offered delivery (58% and 36%) but rarely displayed health warnings (8% and 10%).
conclusionIn NYC, unlicensed retailers outnumber licensed ones and often engage in practices increasing youth access to cannabis. They infrequently verify age, sell cheaper products, and use youth-friendly marketing. Licensed retailers follow age verification laws but are also often near schools and inconsistent with certificates of analysis provision. Further research is needed on policy impacts on youth cannabis use in deregulated markets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.